Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 120 participants.
Also called NCT03098732
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Pulse Therapeutics
- Registry
-
NCT03098732
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Suspended
Technical summary
Registry record NCT03098732. Randomized; double masking; primary purpose treatment. Start 2017-03-22 (actual); primary completion 2019-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial
- Acronym
- MEDIS
- Condition
- Stroke, Acute
- Condition
- Stroke, Ischemic
- Condition
- Infarction, Middle Cerebral Artery
- Condition
- Strokes Thrombotic
- Condition
- Neurologic Disorder
- Condition
- Cerebrovascular Disorders
- Condition
- Intracranial Embolism and Thrombosis
- Intervention (Device)
- Magnetically Enhanced Diffusion (MED)
- Intervention (Device)
- MED Workstation Magnet Sham Control
- Lead sponsor
- Pulse Therapeutics
Record details
- Record id
cardio:ct-nct03098732- Content hash
294f3d8b9597b457fef0fb86f39fa7788cd4dfe5df974cec480aef3da3095764